SCHEMBL13242579

SCHEMBL13242579

CN(N)c1ccc(S(N)(=O)=O)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 16/20 1.00
CA1 P00915 13/20 1.00
CA12 O43570 9/20 1.00
CA9 Q16790 12/20 0.58
MEN1 O00255 1/20 0.58
NPC1 O15118 1/20 0.58
POLB P06746 1/20 0.58
RAB9A P51151 1/20 0.58
KMT2A Q03164 1/20 0.58
CA7 P43166 7/20 0.54
CA5A P35218 5/20 0.54
CA5B Q9Y2D0 5/20 0.54
CA6 P23280 2/20 0.54
CA3 P07451 1/20 0.54
CA4 P22748 3/20 0.52
USP2 O75604 1/20 0.50
TSHR P16473 1/20 0.50
CA13 Q8N1Q1 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
AGO2 Q9UKV8 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL330045 0.84 CA2 (0.78) CA2CA1CA12CA9MEN1
SCHEMBL7570116 0.80 CA2 (0.67) CA2CA1CA12CA9MEN1
SCHEMBL29283437 0.80 CA2 (0.67) CA2CA1CA12CA9MEN1
SCHEMBL8492321 0.78 CA2 (0.70) CA2CA1CA12CA9MEN1
SCHEMBL25033772 0.78 CA2 (0.64) CA2CA1CA12CA9MEN1
SCHEMBL202948 0.77 CA2 (0.81) CA2CA1CA12CA9CA7
SCHEMBL28417720 0.77 CA2 (0.62) CA2CA1CA12CA9MEN1
SCHEMBL9138555 0.75 CA2 (0.60) CA2CA1CA12CA9NPC1
P-Toluenesulfonamide SCHEMBL11327034 0.74 CA2 (0.86) CA2CA1CA12CA9CA7
SCHEMBL28612608 0.74 CA2 (0.59) CA2CA1CA12CA9MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025215303-A1 SULFONAMIDES, COMPOSITIONS COMPRISING SAID SULFONAMIDES, METHODS FOR THE PREPARATION OF SAID SULFONAMIDES, AND SAID SULFONAMIDES FOR USE AS MEDICAMENT AND IN A METHOD FOR THE TREATMENT OR PREVENTION OF AN OCULAR DISEASE OR CONDITION, OR IDIOPATHIC INTRACRANIAL HYPERTENSION ITÄ-SUOMEN YLIOPISTO (FI) 2025-10-16 WO disclosed
US-7756674-B2 Methods of calculating differences of binding affinities between congeneric pairs of ligands by way of a displaced solvent functional THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2010-07-13 US disclosed
US-20090037136-A1 Methods of calculating differences of binding affinities between congeneric pairs of ligands by way of a displaced solvent functional NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2009-02-05 US disclosed